SCHEMBL6473168

SCHEMBL6473168

CC(C)(C)OC(=O)N1CCC(CI)CC1.c1ccc(P(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.58
PKM P14618 1/20 0.58
GPR119 Q8TDV5 10/20 0.54
STS P08842 1/20 0.49
LIMK2 P53671 1/20 0.48
TGFBR1 P36897 1/20 0.48
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4791995 0.88 NAMPT (0.51) KDM4EPKMGPR119STS
SCHEMBL735207 0.84 HPGD (0.54) KDM4EPKMGPR119
SCHEMBL7990377 0.84 GPR119 (0.59) KDM4EPKMGPR119STS
SCHEMBL31607832 0.81 KDM4E (0.54) KDM4EPKMGPR119STSLIMK2
Iodide SCHEMBL7495522 0.80 KDM4E (0.52) KDM4EPKMGPR119STSLIMK2
Iodide SCHEMBL4346071 0.78 JAK2 (0.48) KDM4EPKMGPR119STSTGFBR1
Iodide SCHEMBL4342693 0.78 JAK2 (0.48) KDM4EPKMGPR119STSTGFBR1
SCHEMBL3923737 0.78 KDM4E (0.64) KDM4EPKMGPR119STSMEN1
SCHEMBL8444749 0.78 KDM4E (0.58) KDM4EPKMGPR119STSLIMK2
SCHEMBL1912705 0.77 KDM4E (0.62) KDM4EPKMGPR119STSTGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567511-A1 SUBSTITUTED PIPERAZINES, (1,4) DIASZEPINES, AND 2,5-DIAZABICYCLO (2.2.1) HEPTANES AS HISTAMINE H1 AND/OR H3 ANTAGONISTS OR HISTAMINE H3 REVERSE ANTAGONISTS GLAXO GROUP LIMITED (GB) 2005-08-31 EP disclosed
WO-2004035556-A1 SUBSTITUTED PIPERAZINES, (1,4) DIASZEPINES, AND 2,5-DIAZABICYCLO (2.2.1) HEPTANES AS HISTAMINE H1 AND/OR H3 ANTAGONISTS OR HISTAMINE H3 REVERSE ANTAGONISTS GLAXO GROUP LIMITED (GB) 2004-04-29 WO disclosed